We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YPF:NYSEYPF Sociedad Anonima Analysis

Data as of 2026-08-14 - not real-time

$50.05

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

YPF Sociedad Anónima is priced at $50.05 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 12.7%. RSI sits at 51.0, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $47.86 and resistance around $53.57.
Valuation screens as undervalued: a P/E of 1.3 sits below the sector average of 20.9. The average analyst target implies 17.1% above today's level. Revenue is growing at 72.2% on a 4.0% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 35.3%, a beta of 0.30 and a maximum drawdown of 30.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.

Top Market Events

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs and personal...3dYPF Sociedad Anónima Q2 Earnings Call HighlightsYPF Sociedad Anónima NYSE:YPF reported record second-quarter 2026...Detailed price information for Ypf Sociedad Anonima ADR YPF-N from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 42.15
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 1.3 versus sector average of 20.9
  • Trading above the 200-day average of 42.15

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 1.3 versus sector average of 20.9
  • Analyst targets imply +17.1% versus the current price
  • Revenue growth of +72.2%

Key Metrics & Analysis

Financial Health

Revenue Growth72.20%
Profit Margin4.00%
P/E Ratio1.3
ROE7.26%
ROA8.34%
Debt/Equity84.75
P/B Ratio1.9
Op. Cash Flow$10978.2B
Free Cash Flow$1244.1B
Industry P/E20.9

Technical Analysis

TrendBullish
RSI51.0
Support$47.86
Resistance$53.57
MA 20$50.50
MA 50$49.90
MA 200$42.15
MACDBearish
VolumeIncreasing
Fear & Greed Index95.98

Valuation

Fair Value$80,299.00
Target Price$58.60
Upside/Downside17.08%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.30
Volatility35.31%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.